ARS Pharmaceuticals Inc. logo

ARS Pharmaceuticals Inc.

SPRY | NASDAQ
Chart Builder DCF Calculator
$4.35
+$0.24 (+5.84%)
At close: Sep 21, 2026, 4:00 PM ET
$4.35
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
41.32M 50.82M 70.97M 210.52M 60.06M 24.52M
Short-Term Investments
203.67M 263.21M 157.39M 63.86M n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
25.84M 8.11M 801K 2.96M 23K 2K
Receivables
26.35M 9.16M 795K n/a 1K 384K
Inventory
8.37M 5.21M n/a n/a n/a n/a
Other Current Assets
5.19M 1.23M n/a 1.01M n/a n/a
Total Current Assets
284.9M 334.3M 231.56M 277.7M 60.73M 26.38M
Property-Plant & Equipment
2.47M 1.07M 824K 774K 693K 23K
Goodwill & Intangibles
14.45M 7.69M n/a n/a n/a n/a
Total Long-Term Assets
42.76M 16.86M 1.63M 3.74M 716K 25K
Total Assets
327.65M 351.15M 233.19M 281.44M 61.45M 26.41M
Account Payables
5.73M 9.87M 759K 1.66M 1.79M 1.22M
Deferred Revenue
609K 557K n/a n/a 1.46M 3.52M
Short-Term Debt
n/a n/a 237K n/a 3.48M 2.56M
Other Current Liabilities
588K 2.29M 1.08M 1.46M 660K n/a
Total Current Liabilities
39.15M 23.44M 2.39M 5.44M 8.19M 8.21M
Long-Term Debt
96.37M n/a n/a n/a 4.93M 7.46M
Other Long-Term Liabilities
76.75M 69.38M n/a 2.85M 76.12M 21.35M
Total Long-Term Liabilities
174.25M 70.92M 37K 3.11M 84.53M 32.25M
Total Liabilities
213.39M 94.36M 2.43M 8.55M 92.72M 40.46M
Total Debt
96.37M 42K 274K 481K 9.03M 10.02M
Book Value
114.26M 256.8M 230.76M 272.89M -31.27M -14.05M
Book Value Per Share
1.16 2.51 2.42 6.83 -1.08 -0.40
Common Stock
10K 10K 10K 9K 3K 223K
Retained Earnings
-294.6M -123.31M -131.3M -76.94M -42.26M -22.01M
Comprehensive Income
125K 220K 49K 407K n/a n/a
Shareholders Equity
114.26M 256.8M 230.76M 272.89M -31.27M -14.05M
Total Investments
203.67M 263.21M 157.39M 63.86M n/a n/a

© 2026 bestshares.com. All rights reserved.